Zentalis Pharmaceuticals, Inc. - ZNTL

SEC FilingsOur ZNTL Tweets

About Gravity Analytica

Recent News

  • 10.01.2025 - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 10.01.2025 - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
  • 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
  • 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
  • 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
  • 09.04.2025 - 2025 Wells Fargo Healthcare Conference
  • 09.04.2025 - 2025 Wells Fargo Healthcare Conference
  • 09.02.2025 - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 09.02.2025 - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

  • 09.22.2025 - 3 Initial statement of beneficial ownership of securities
  • 08.26.2025 - 8-K Current report
  • 08.26.2025 - EX-99.1 EX-99.1
  • 08.06.2025 - 8-K Current report